A decisive lifesaving tool in submassive pulmonary embolism: Bedside echocardiography-Reference-Cited by-全球学者库

A decisive lifesaving tool in submassive pulmonary embolism: Bedside echocardiography

Published:2023-12 Issue:12 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Khanal Shambhu¹^ORCID,Adhikari Suman²,Yadav Vijay²,Aryal Savita³,Thapa Shreya⁴,Gajurel Ratna Mani²

Affiliation:

1. Department of Internal Medicine Lumbini Provincial Hospital Butwal Nepal

2. Department of Cardiology, Institute of Medicine Tribhuvan University Teaching Hospital Maharajgunj Nepal

3. Department of Emergency Lumbini Provincial Hospital Butwal Nepal

4. Department of Internal Medicine Nepalgunj Medical College Nepalgunj Nepal

Abstract

Key Clinical MessageImmediate thrombolysis in submassive pulmonary embolism on the basis of bedside echocardiography can be a lifesaving decision in areas where computed tomography (CT) pulmonary angiogram is not readily available.AbstractBedside echocardiography can be a rapid diagnostic and decision‐making tool for immediate thrombolysis in submassive pulmonary embolism with evidence of progressively failing ventricles. We report a case of submassive pulmonary embolism in a 26‐year‐old male under testosterone replacement therapy, who was successfully thrombolyzed based on bedside echocardiography findings.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.8314

Reference20 articles.

1. Acute Pulmonary Embolism

2. Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism;Bĕlohlávek J;Exp Clin Cardiol,2013

3. Pulmonary embolism secondary to testosterone‐enhancing herbal supplement use;Nguyen SM;Cureus,2017

4. Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels

5. Testosterone Increases Human Platelet Thromboxane A 2 Receptor Density and Aggregation Responses